Defining the dynamics of self-assembled Fas-receptor activation

Trends in Immunology

Volumn 23, Issue 4, 2002, Pages 187-194

  Mundle, Suneel D ^a   Raza, Azra ^a  

^a RUSH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CYTOCHROME C; DD ASSOCIATED PROTEIN; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; HEAT SHOCK PROTEIN 27; INTERLEUKIN 1BETA; INTERLEUKIN 2; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; RECEPTOR INTERACTING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DEATH; CELL MEDIATED CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; LYMPHOCYTE PROLIFERATION; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; OLIGOMERIZATION; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CYTOKINES; FAS LIGAND PROTEIN; MEMBRANE GLYCOPROTEINS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

EID: 0036533670     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(02)02192-0     Document Type: Review

References (57)

1. Advances in apoptosis research
2. Mutations in apoptosis genes: A pathogenetic factor for human diseases
3. TNF-α and the TNF-α receptor superfamily: Structure-function relationship(s)
4. Two CD95 (APO-1/Fas) signaling pathways
5. Fas ligand - Caught between Scylla and Charybdis
6. L
7. Caspases: The executioners of apoptosis
8. Inhibition of death receptor signals by cellular FLIP
9. Induction of apoptosis by cancer chemotherapy
10. The biochemistry of apoptosis
11. Cell-type-specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis
12. RAIDD is a new 'death' adapter molecule
13. Inhibition of Daxx-mediated apoptosis by heat-shock protein 27
14. Regulation of Rb and E2F1 by signal-transduction cascades; divergent effects of JNK1 and p38 kinases
15. Induction of DNA synthesis and apoptosis are separable functions of E2F1
16. Fas and Fas-ligand expression in human pancreatic cancer
17. Fas-ligand-induced c-Jun kinase activation in lymphoid cells requires extensive receptor aggregation but is independent of DAXX, and Fas-mediated cell death does not involve DAXX, RIP or RAIDD
18. CD95's deadly mission in the immune system
19. Downregulation of Fas ligand by shedding
20. Fas/Fas ligand and hematopoietic progenitor cells
21. Quantitative analysis of Fas and Bcl-2 expression in hematopoietic precursors
22. CD95 (Apo-1/Fas)-mediated apoptosis in cytokine-activated hematopoietic cells
23. Role of TNF in lymphocyte-mediated cytotoxicity
24. Down-regulation of Fas-associated phosphatase 1 (Fap-1) in interleukin-2-activated T cells
25. Bile salts mediate hepatocyte apoptosis by increasing cell-surface trafficking of Fas
26. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity
27. - hematopoietic progenitor cells by suppressing apoptosis
28. Fap-1: A protein tyrosine phosphatase that associates with Fas
29. The molecular interaction of Fas and Fap-1; a tripeptide blocker of human Fas interaction with Fap-1 promotes Fas-induced apoptosis
30. Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis
31. Expression of Fap-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T-cell lines derived from human T-cell-leukemia-virus-type-1-associated myelopathy/tropical spastic paraparesis patients
32. Immunohistochemical localization of Fap-1, an inhibitor of Fas-mediated apoptosis, in normal and neoplastic human tissues
33. Spontaneous down-regulation of Fas-associated phosphatase 1 may contribute to excessive apoptosis in myelodysplastic marrows
34. Negative regulation of Fas-mediated apoptosis by Fap-1 in human cancer cells
35. Expression and potential role of Fas-associated phosphatase 1 in ovarian cancer
36. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma
37. mRNA expression of Fas receptor (CD95)-associated proteins (Fas-associated phosphatase 1/Fap-1, Fas-associating protein with death domain/FADD and receptor-interacting protein/RIP) in human leukemia/lymphoma cell lines
38. Metabolic inhibitors sensitize for CD95 (apo-1/Fas)-induced apoptosis by down-regulating Fas-associated death-domain-like interleukin-1-converting enzyme inhibitory protein expression
39. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase-8) to the CD95 death-inducing signaling complex
40. Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver
41. Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells
42. Ceramide enables Fas to cap and kill
43. Fas aggregation does not correlate with Fas-mediated apoptosis
44. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations
45. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling
46. FasL binds preassembled Fas
47. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis
48. Altered mechanisms of apoptosis in colon cancer: Fas resistance and counter-attack in the tumor-immune conflict
49. Self-association of the death domains of the p55 tumor necrosis factor (TNF) receptor and Fas/Apo1 prompts signaling for TNF and Fas/Apo1 effects
50. Fas (Apo-1, CD95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor
51. Characterization of Fap-1 expression and function in thyroid follicular cells
52. Two signaling pathways can increase Fas expression in human thymocytes
53. Functional Fas expression in human thymic epithelial cells
54. Anti-proliferative effect of IFN-γ in immune regulation IV: Murine CTL clones produce IL-3 and GM-CSF, the activity of which is masked by the inhibitory action of secreted IFN-γ
55. Evaluation of the inhibitory effects of budesonide on the mitogen-induced or the allergen-induced activation of blood mononuclear cells isolated from asthmatic patients
56. Fap-1 in pancreatic cancer cells: Functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis
57. Death-receptor contribution to the germinal-center reaction